Price T Rowe Associates Inc Portfolio Holdings

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

Price T Rowe Associates Inc has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $867 Billion distributed in 4519 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $57B, Nvidia Corp with a value of $55.2B, Apple Inc. with a value of $55.1B, Amazon Com Inc with a value of $40.1B, and Meta Platforms, Inc. with a value of $24.8B.

Examining the 13F form we can see an decrease of $1.1B in the current position value, from $869B to 867B.

Price T Rowe Associates Inc is based out at Baltimore, MD

Below you can find more details about Price T Rowe Associates Inc portfolio as well as his latest detailed transactions.

Portfolio value $867 Billion
Technology: $280 Billion
Healthcare: $109 Billion
Consumer Cyclical: $100 Billion
Financial Services: $95.5 Billion
Communication Services: $82.8 Billion
Industrials: $64.8 Billion
Energy: $32.4 Billion
Consumer Defensive: $26 Billion
Other: $51.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$23.4B
$86 Million 0.01% of portfolio
263,268
Q4 2024 Reduced 57.26%
$5.84B
$91.6 Million 0.01% of portfolio
3,011,333
Q4 2024 Reduced 8.25%
$5.8B
$74.6 Million 0.01% of portfolio
512,353
Q4 2024 Reduced 0.36%
$9.37B
$74.3 Million 0.01% of portfolio
610,135
Q4 2024 Reduced 3.15%
$5.28B
$67.3 Million 0.01% of portfolio
331,099
Q4 2024 Reduced 0.11%
$2.27B
$53.8 Million 0.01% of portfolio
1,392,652
Q4 2024 Added 6.35%
$2.76B
$52.5 Million 0.01% of portfolio
418,303
Q4 2024 Reduced 13.27%
$12.4B
$49.3 Million 0.01% of portfolio
589,906
Q4 2024 Reduced 43.41%
$15.2B
$129 Million 0.01% of portfolio
6,622,493
Q4 2024 Reduced 2.0%
$7.55B
$119 Million 0.01% of portfolio
656,097
Q4 2024 Added 53.94%
$2.91B
$49.7 Million 0.01% of portfolio
1,711,039
Q4 2024 Added 20.51%
$4.09B
$78.3 Million 0.01% of portfolio
695,396
Q4 2024 Added 2.78%
$11.5B
$58.8 Million 0.01% of portfolio
1,766,841
Q4 2024 Reduced 6.61%
$19.9B
$107 Million 0.01% of portfolio
3,921,832
Q4 2024 Reduced 47.19%
$8.26B
$74.1 Million 0.01% of portfolio
309,617
Q4 2024 Added 199.44%
$3.98B
$53.1 Million 0.01% of portfolio
649,314
Q4 2024 Reduced 14.4%
$5.68B
$45.3 Million 0.01% of portfolio
1,951,857
Q4 2024 Reduced 26.57%
$1.57B
$126 Million 0.01% of portfolio
2,306,313
Q4 2024 Added 20.4%
$15.1B
$48.8 Million 0.01% of portfolio
774,523
Q4 2024 Reduced 47.9%
$9.14B
$122 Million 0.01% of portfolio
1,955,180
Q4 2024 Reduced 18.84%
$2.36B
$57.5 Million 0.01% of portfolio
713,856
Q4 2024 Reduced 8.18%
$2.91B
$61.7 Million 0.01% of portfolio
2,354,025
Q4 2024 Added 30.37%
$36.1B
$105 Million 0.01% of portfolio
6,777,848
Q4 2024 Reduced 1.23%
$1.6B
$43.6 Million 0.01% of portfolio
178,411
Q4 2024 Added 55.8%
$4.33B
$79.8 Million 0.01% of portfolio
509,459
Q4 2024 Added 16.25%
Soleno Therapeutics Inc
-
$73.3 Million 0.01% of portfolio
-
Q4 2024 Added 24.53%
$6.81B
$60.4 Million 0.01% of portfolio
1,763,973
Q4 2024 Added 12.68%
$10.7B
$43.6 Million 0.01% of portfolio
455,039
Q4 2024 Reduced 81.74%
$6.87B
$89.6 Million 0.01% of portfolio
323,324
Q4 2024 Added 1,288.13%
$4.25B
$44.5 Million 0.01% of portfolio
99,651
Q4 2024 Reduced 5.15%
$0
$44.7 Million 0.01% of portfolio
76,331
Q4 2024 Added 53.66%
$5.81B
$51.1 Million 0.01% of portfolio
483,349
Q4 2024 Reduced 35.67%
$24.6B
$44.6 Million 0.01% of portfolio
1,368,263
Q4 2024 Reduced 24.13%
$4.57B
$67.1 Million 0.01% of portfolio
364,768
Q4 2024 Reduced 4.26%
$5.81B
$49 Million 0.01% of portfolio
944,175
Q4 2024 Added 3.97%
$23.7B
$92.2 Million 0.01% of portfolio
877,238
Q4 2024 Added 6.96%
$13.5B
$109 Million 0.01% of portfolio
1,789,172
Q4 2024 Reduced 2.65%
$17.8B
$50.1 Million 0.01% of portfolio
2,129,832
Q4 2024 Added 0.18%
$26.7B
$47 Million 0.01% of portfolio
377,643
Q4 2024 Reduced 0.9%
$856M
$89.9 Million 0.01% of portfolio
3,557,136
Q4 2024 Added 23.5%
$2.96B
$108 Million 0.01% of portfolio
372,259
Q4 2024 Added 65.47%
$36B
$61 Million 0.01% of portfolio
514,702
Q4 2024 Added 1.31%
$5.17B
$74.8 Million 0.01% of portfolio
772,879
Q4 2024 Reduced 0.42%
$49.5B
$117 Million 0.01% of portfolio
111,073
Q4 2024 Added 78.62%
$4.07B
$67.8 Million 0.01% of portfolio
1,891,602
Q4 2024 Added 35.67%
$6.76B
$128 Million 0.01% of portfolio
4,969,893
Q4 2024 Reduced 70.61%
$70.5M
$49,000 0.0% of portfolio
15,771
Q4 2024 Added 22.93%
Rapport Therapeutics Inc
-
$20.3 Million 0.0% of portfolio
-
Q4 2024 Added 9.16%
Madison Square Garden Entmt
-
$1.15 Million 0.0% of portfolio
-
Q4 2024 Added 9.58%

Summary

  • Portfolio
  • No. of Stocks 4,519
  • Current Value $867 Billion
  • Prior Value $869 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 106 stocks
  • Additional Purchases 1,808 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 941 stocks
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email